• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-21A
Device Problem Material Split, Cut or Torn (4008)
Patient Problems Dyspnea (1816); Heart Failure (2206); No Known Impact Or Consequence To Patient (2692)
Event Date 07/20/2020
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.Investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2017, a 21mm trifecta gt valve was implanted in the patient's aortic position.The patient complained of dyspnea on (b)(6) 2020, and was hospitalized on (b)(6) 2020 to control the heart failure.The valve damage was suspected in echocardiogram performed on (b)(6) which led to a re-do avr on (b)(6) 2020.The trifecta gt valve was explanted, replaced with a 21mm inspiris resilia aortic valve(manufacturer: edwards lifesciences).Upon explant, the valve was torn largely from the lcc and the ncc stent post, to the lcc side.The surgeon attributed the issue to the valve; he often heard of problems of tears occurring on the trifecta gt valves.The sales rep.Thought that the issue was acute aortic regurgitation that often occur on the trifecta gt valves.
 
Manufacturer Narrative
The reported event of dyspnea, heart failure, and a torn cusp could not be confirmed.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (CVD)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
MDR Report Key10528680
MDR Text Key206784922
Report Number3008452825-2020-00472
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018212
UDI-Public05415067018212
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Replace
Type of Report Initial,Followup
Report Date 09/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/25/2021
Device Model NumberTFGT-21A
Device Catalogue NumberTFGT-21A
Device Lot Number6062618
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/08/2020
Initial Date FDA Received09/14/2020
Supplement Dates Manufacturer Received09/24/2020
Supplement Dates FDA Received09/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-